This is a Continuing Medical Education article, and can be found with corresponding questions on the Internet at http://www.efns.org/EFNSContinuing-Medical-Education-online.301.0.html. Certificates for correctly answering the questions will be issued by the EFNS.
1468-1331/asset/olbannerleft.jpg?v=1&s=5d3a3e0b13870c31eb751e2f9ac484568b81fd0e)
EFNS guideline on the treatment of tension-type headache – Report of an EFNS task force
Article first published online: 11 MAY 2010
DOI: 10.1111/j.1468-1331.2010.03070.x
© 2010 The Author(s). Journal compilation © 2010 EFNS
Additional Information
How to Cite
Bendtsen, L., Evers, S., Linde, M., Mitsikostas, D. D., Sandrini, G. and Schoenen, J. (2010), EFNS guideline on the treatment of tension-type headache – Report of an EFNS task force. European Journal of Neurology, 17: 1318–1325. doi: 10.1111/j.1468-1331.2010.03070.x
Publication History
- Issue published online: 11 MAY 2010
- Article first published online: 11 MAY 2010
- Received 9 February 2010 Accepted 26 March 2010
- Abstract
- Article
- References
- Cited By
Keywords:
- antidepressants;
- guideline;
- prophylaxis;
- tension-type headache;
- treatment
Background: Tension-type headache (TTH) is the most prevalent headache type and is causing a high degree of disability. Treatment of frequent TTH is often difficult.
Objectives: To give evidence-based or expert recommendations for the different treatment procedures in TTH based on a literature search and the consensus of an expert panel.
Methods: All available medical reference systems were screened for the range of clinical studies on TTH. The findings in these studies were evaluated according to the recommendations of the EFNS resulting in level A, B or C recommendations and good practice points.
Recommendations: Non-drug management should always be considered although the scientific basis is limited. Information, reassurance and identification of trigger factors may be rewarding. Electromyography (EMG) biofeedback has a documented effect in TTH, whilst cognitive-behavioural therapy and relaxation training most likely are effective. Physical therapy and acupuncture may be valuable options for patients with frequent TTH, but there is no robust scientific evidence for efficacy. Simple analgesics and non-steroidal anti-inflammatory drugs are recommended for the treatment of episodic TTH. Combination analgesics containing caffeine are drugs of second choice. Triptans, muscle relaxants and opioids should not be used. It is crucial to avoid frequent and excessive use of analgesics to prevent the development of medication-overuse headache. The tricyclic antidepressant amitriptyline is drug of first choice for the prophylactic treatment of chronic TTH. Mirtazapine and venlafaxine are drugs of second choice. The efficacy of the prophylactic drugs is often limited, and treatment may be hampered by side effects.